Ultrasound-Guided Thermocoagulation of Medial Nerve Branch in Lumbar Facet Joints Pain.
Unknown statusNot applicableNCT03564418
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
We propose here to evaluate the precision of lumbar thermocoagulation performed under a transverse ultrasound approach by performing a fluoroscopic control once the needle in the desired position. The effectiveness of the technique will be assessed by measuring different pain and disability scores at six weeks post-thermocoagulation: the Visual analogue pain Scale score (VAS) and the Oswestry disability score (ODI) will be collected, compared to that of the conventional fluoroscopic technique.
Study details
- Official title
- Ultrasound-Guided Thermocoagulation of Medial Nerve Branch in Lumbar Facet Joints Pain. Effectiveness and Benefits of a Non Irradiating Technique.
- Conditions
- Low Back Pain
- Facet Joint Pain
- Facet Syndrome of Lumbar Spine
- Chronic Low Back Pain
- Interventions
- Procedure: Ultrasound-Guided Thermocoagulation of Lumbar facet joints
- Procedure: Fluoroscopy-Guided Thermocoagulation of Lumbar facet joints
- Sponsor
- Erasme University Hospital
- Start date
- 2018-01-02
- Primary completion
- 2018-06-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Over the age of 18. * Facet Syndrome. * Symptomatology superior than 3 mounths. * A failure of conservative treatement (drugs, physiotherapy...) * Partial improvement after two lumbar facet infiltrations. Exclusion Criteria: * Allergy to any of the constituents of the infiltrated product, or to the contrast medium * Unstable medical condition: cardiac, respiratory, endocrine (uncontrolled diabetes) * Local infection (cutaneous, perimedullary / spinal) or systemic. * Coagulopathy (platelets \<50000 / mm3, Prothrombin time \<60%, INTernational normalized ratio\> 1.5), anticoagulant or antiplatelet therapy treatment other than aspirin. * Lumbar arthrodesis. * Neurological condition affecting motor function (Stroke, Parkinson...) * Pregnant woman.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03564418